Articles

In a political system whose primary currency is not the vote but the dollar, McConnell’s role as leader has plainly been well-earned.

Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.

The “maximum fair price” for a drug must not only be equitable to those with unmet medical needs who may benefit from the use of the drug but also provide equitable returns on both public and private sector investments.

Eric Laursen, author of The People’s Pension, explains to INET’s Lynn Parramore what’s at stake for Americans in a year of sneak attacks and misinformation.

Germany’s debt brake and EU fiscal rules will make it well neigh impossible for EU countries to fund the investments needed to decarbonize their economies.

The famed short-seller talks Sam Bankman-Fried, why Wall Street is still so keen on crypto, and how technology is making us dumber.

Recent developments in AI have added fuel to debates that have long simmered amongst economists, which could lead to a rethinking of economics itself.

What lessons need to be drawn on this anniversary?

By all accounts infection rates have ebbed. But were we good or were we lucky?

The bundle of sanctions was initially designed and imposed in haste, with little basis to assess historic performance.